News

South Korea’s Genexine to initiate phase 1 trials of DNA vaccine against COVID-19

Genexine received approval for clinical phase 1/2a of GX-19, a DNA vaccine against COVID-19, by the country’s Ministry of Food and Drug Safety.

Read More

Jun 25, 2020

By : Team ABLE

DKSH to sell, distribute seven Biocon Pharma’s generic formulations in Singapore and Thailand

DKSH will gain an exclusive license to register and commercialize seven generic formulations from various therapeutic areas and will be sold under Biocon’s brand in Singapore and Thailand.

Read More

Jun 24, 2020

By : Team ABLE

AarogyaAI Innovations from India among seven genomic startups selected by Illumina Accelerator

AarogyaAI Innovations Pvt Ltd, a diagnostics company from India, comprehensively diagnoses drug-resistance in tuberculosis rapidly.

Read More

Jun 24, 2020

By : Team ABLE

C-CAMP, Applied Materials India assist biotech startups to increase availability of indigenous medical supplies during COVID-19

Two startups, Coeo Labs and Biomoneta, were chosen by C-CAMP’s COVID-19 Innovations Deployment Accelerator (C-CIDA).

Read More

Jun 24, 2020

By : Team ABLE

NIH investigators reveal research findings on CD47 causing broad-spectrum infectious diseases immunotherapy

Their new study in mBio describes this brake and the way pathogens such as SARS-CoV-2, the virus that causes COVID-19, turn it on.

Read More

Jun 24, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights